Status:
COMPLETED
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
Lead Sponsor:
Erasme University Hospital
Conditions:
Alcoholic Liver Disease
Chronic Hepatitis C Virus
Eligibility:
All Genders
18+ years
Brief Summary
Alcoholic liver disease is characterized by circulating T cell activation and liver T cell infiltration but their phenotype is poorly studied. The aim of the study is to test the hypothesis that the (...
Detailed Description
Consecutive patients undergoing transjugular liver biopsies for alcoholic liver disease or hepatitis C virus infection will be included in the study to measure plasma cytokines levels, peripheral bloo...
Eligibility Criteria
Inclusion
- Alcohol excess intake and suspected liver disease
- Alcohol excess intake and clinical liver cirrhosis
- chronic hepatitis C virus infection and suspected liver disease
- chronic hepatitis C virus infection and clinical liver cirrhosis
Exclusion
- bacterial or fungal infection
- immunosuppressive treatment
- other causes of liver disease
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00610597
Start Date
January 1 2005
End Date
January 1 2008
Last Update
February 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Erasme - Dpt of Gastroenterology
Brussels, Belgium